三诺生物:2024H1血糖业务毛利率持续提升,盈利能力增强

| --- | --- | --- | |-------------------------------------|----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...